Myriad Genetics
Business Services · Utah, United States · 1K - 5K Employees
View Company Info for Free
Overview
Headquarters
322 N 2200 W, Salt Lake City, Utah, 8411...Phone Number
(801) 584-3600Website
www.myriad.comRevenue
$806.6 MillionStock Symbol
MYGNIndustry
About Myriad Genetics
Myriad Genetics, Inc. is a molecular diagnostic testing and precision medicine company headquartered in Salt Lake City, Utah. Founded in 1991, the company discovers, develops, and commercializes genetic and genomic tests that assess disease risk, guide treatment decisions, and monitor disease progression across hereditary cancer, oncology, urology, prenatal health, reproductive health, and mental health. Its offerings include hereditary cancer risk panels, prostate cancer prognostic tests, pharmacogenomic testing for mental health medications, and companion diagnostics designed to work alongside targeted cancer therapies.Explore more
SIC Code 38,382NAICS Code 33,334Ticker NASDAQ: MYGNShow moreMyriad Genetics Org Chart
Compare Similar Companies to Myriad Genetics
Compare insights from companies similar to Myriad Genetics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$3.2B
5K - 10K
Private
$56M
1995
$705.2M
1K - 5K
Private
-
1993
RP
Rushi PotdarChief Medical Officer & Head of Global Medical Affairs, Global Oncology Business Unit (Gobu)
Myriad Genetics Tech Stack
A closer look at the technologies used by Myriad Genetics
See more technologies
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Myriad Genetics
Sign Up For FreeTo access detailed company insights
Myriad Genetics, Inc. is a molecular diagnostic testing and precision medicine company headquartered in Salt Lake City, Utah. Founded in 1991, the company discovers, develops, and commercializes genetic and genomic tests that assess disease risk, guide treatment decisions, and monitor disease progression across hereditary cancer, oncology, urology,... Read More
